|
|
| Research article summary (published 29 Apr 2006): |
|
Free Full Text! See links below |
Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease.
Full Abstract
OBJECTIVE:
To examine the clinical differences and the type and extent of organ damage in late- versus early-onset systemic lupus erythematosus (SLE).
METHODS:
A nested case-control study was performed in the context of LUMINA (LUpus in MInorities, NAture versus nurture), a large, longitudinal, multiethnic cohort. Patients who developed SLE at or after the age of 50 years were considered cases. Two controls (patients who developed SLE at age < or = 49 years) per case, matched for sex and disease duration, were randomly chosen. Selected baseline socioeconomic/demographic, behavioral, and psychological features, self-reported quality of life, and cumulative clinical data (clinical manifestations, laboratory data, disease activity, damage, and mortality) were compared between cases and controls. Multivariable analyses with late-onset lupus, damage accrual, and mortality as dependent variables were then performed.
RESULTS:
Two hundred seventeen patients were studied. Of them, 73 were cases. Cases were more likely to have neurologic involvement, arterial thrombotic events, osteoporosis, and hypertriglyceridemia, while renal involvement and anti-Sm antibodies were less frequent. Disease activity at baseline was lower among cases. Cases also exhibited more cardiovascular and ocular damage. Late-onset lupus was an independent predictor of damage accrual (t-test = 2.23, P = 0.028), any damage at last visit (odds ratio [OR] 23.32, 95% confidence interval [95% CI] 3.98-141.56) (P < 0.001), and mortality (OR 10.74, 95% CI 3.07-37.56) (P < 0.001).
CONCLUSION:
Patients with late-onset lupus exhibit distinct clinical features. Although disease activity tends to be lower in these patients, they tend to accrue more damage and experience higher mortality than patients with early-onset lupus. These findings probably reflect the contribution exerted by other comorbid conditions in the overall impact of lupus in these patients.
Learn Faster Today Improve your study skills
Author information
Author/s: Bertoli, Ana M (AM); Alarcón, Graciela S (GS); Calvo-Alén, Jaime (J); Fernández, Mónica (M); Vilá, Luis M (LM); Reveille, John D (JD); LUMINA Study Group;
Affiliation: University of Alabama at Birmingham School of Medicine, USA.
Grants: 1P20-RR-11126 (Agency:NCRR NIH HHS) ; M01-RR-00032 (Agency:NCRR NIH HHS) ; M01-RR-02558 (Agency:NCRR NIH HHS) ; R01-AR-42503 (Agency:NIAMS NIH HHS)
Journal and publication information
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal: Arthritis and rheumatism (Arthritis Rheum), published in United States. (Language: eng)
Reference: 2006-May; vol 54 (issue 5) : pp 1580-7
Dates: Created 2006/05/09; Completed 2006/08/04; Revised 2007/11/14;
PMID: 16645994, status: MEDLINE (last retrieval date: 12/26/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
Comments and Corrections
ErratumIn: Arthritis Rheum. 2006 Jul;54(7):2320.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
Related articles
These are the highest related articles currently in the database:
- Prevalence of physician-diagnosed systemic lupus erythematosus in the United States: results from the third national health and nutrition examination survey.
29 Jun 2004 - Lack of recording of systemic lupus erythematosus in the death certificates of lupus patients.
12 Jun 2005 - Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients.
27 Feb 2006 - Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus.
30 Aug 2003 - Cardiac valvular disease in patients with systemic lupus erythematosus. Relationship with anticardiolipin antibodies.
12 Oct 2003 - Collagen vascular diseases.
30 Aug 2004 - Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients.
30 Dec 2004 - Systemic lupus erythematosus in Asturias, Spain: clinical and serologic features.
29 Apr 2006 - Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
28 Feb 2007 - Aberrant HS1 molecule in a patient with systemic lupus erythematosus.
27 Feb 2003
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.